PlainRecalls
FDA Drug Moderate Class II Terminated

Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA, NDC 0378-5265-98.

Reported: February 1, 2017 Initiated: December 20, 2016 #D-0444-2017

Product Description

Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA, NDC 0378-5265-98.

Reason for Recall

Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.

Details

Recalling Firm
Mylan LLC.
Units Affected
588 bottles
Distribution
Nationwide in the USA
Location
Caguas, PR

Frequently Asked Questions

What product was recalled?
Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA, NDC 0378-5265-98.. Recalled by Mylan LLC.. Units affected: 588 bottles.
Why was this product recalled?
Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 1, 2017. Severity: Moderate. Recall number: D-0444-2017.